Single dose versus 5-day course of oral prulifloxacin in antimicrobial prophylaxis for transrectal prostate biopsy;Ruolo della profilassi antibatterica nel mapping prostatico: Esperienza con prulifloxacina

Minerva Urologica e Nefrologica

Volumn 59, Issue 1, 2007, Pages 1-10

  Mari, M ^a,b  

^a Ospedale di Rivoli   (Italy)

^b OSPEDALE DEGLI INFERMI   (Italy)

Author keywords

Fine needle biopsy; Prostatic diseases; Prulifloxacin

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN; FOSFOMYCIN TROMETAMOL; METRONIDAZOLE; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BLEEDING; CHRONIC PROSTATITIS; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; HEMATURIA; HEMOSPERMIA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATIENT COMPLIANCE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; BIOPSY; DIOXOLANES; DRUG ADMINISTRATION SCHEDULE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; QUINOLONES;

EID: 34250857364     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gruppo Italiano Biopsia Prostatica. Linee guida biopsia prostatica. Arch Ital Urol Androl 2005;77 Suppl 1:1-79.
2. th ed. Philadelphia: Saunders; 1992.p.1159-221.
3. Irani J, Fournier F, Bon D, Gremmo E, Dore B, Aubert J. Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol 1997;79:608-10.
4. Aus G, Hermansson CG, Hugosson J, Pedersen KV. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol 1993;71:457-9.
5. Aus G, Ahlgren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate - risk factors and antibiotic prophylaxis. Br J Urol 1996;77: 851-5.
6. Schroder FH, Alexander FE, Bangma CH, Hugosson J, Smith DS. Screening and early detection of prostate cancer. Prostate 2000;44:255-63.
7. Thompson PM, Pryor JP, Williams JP, Eyers DE, Dulake C, Scully MF et al. The problem of infection after prostatic biopsy: the case for the transperineal approach. Br J Urol 1982;54:736-40.
8. Gustafsson O, Norming U, Nyman CR, Ohstrom M. Complications following combined transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 1990;24:249-51.
9. Torp-Pedersen S, Lee F, Littrup PJ, Siders DB, Kumasaka GH, Solomon MH et al. Transrectal biopsy of the prostate guided with transrectal US: longitudinal and multiplanar scanning. Radiology 1989;170 (1 Pt 1):23-7.
10. Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol 1997;79:777-80.
11. Puig J, Darnell A, Bermudez P, Malet A, Serrate G, Bare M et al. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? Eur Radiol 2006;16:939-43.
12. Trinchieri A, Mangiarotti B, Lizzano R. Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology. Arch Ital Urol Androl 2002;74: 33-9.
13. Crawford ED, Haynes AL Jr, Story MW, Borden TA. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 1982;127:449-51.
14. Naber KG, Hofstetter AG, Bruhl P, Bichler K, Lebert C. Guidelines for the perioperative prophylaxis in urological interventions of the urinary and male genital tract. Int J Antimicrob Agents 2001;17:321-6.
15. Schaeffer EM. Prophylactic use of antimicrobials in commonly performed outpatient urologic procedures. Nat Clin Pract Urol 2006;3:24-31.
16. Sheikh M, Hussein AY, Kehinde EO, Al-Saeed O, Rad AB, Ali YM, Anim JT. Patients' tolerance and early complications of transrectal sonographically guided prostate biopsy: prospective study of 300 patients. J Clin Ultrasound 2005;33:452-6.
17. Sabbagh R, McCormack M, Peloquin F, Faucher R, Perreault JP, Perrotte P et al. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol 2004;11:2216-9.
18. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 1997;157:2199-200.
19. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 1998;160(6 Pt 1):2115-20.
20. Veliev EI. [Antibacterial prophylaxis of bacteriuria at transrectal multifocal prostatic biopsy] Antibiot Khimioter 2002;47:3-5. Russian.
21. Cormio L, Berardi B, Callea A, Fiorentino N, Sblendorio D, Zizzi V et al. Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 2002;90: 700-2.
22. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 2000;85:682-5.
23. Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirli I. Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 1999;31: 491-5.
24. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552-8.
25. Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 2002;168:1021-3.
26. Tobias-Machado M, Correa TD, De Barros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol 2003;29:313-9.
27. Argyropoulos AN, Doumas K, Farmakis A, Liakatas I, Gkialas I, Lykourinas M. Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy. Int Urol Nephrol 2007 Jan 4; [Epub ahead of print]
28. Keam SJ, Perry CM. Prulifloxacin. Drugs 2004;64:2221-34; discussion 2235-6.
29. Montanari MP, Mingoia M, Varaldo PE. In vitro antibacterial activities of AF3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates. Antimicrob Agents Chemother 2001;45: 3616-22.
30. Prats G, Roig C, Mirò E, Navarro F, Mirelis B. In vitro activity of AF3013, the active metabolite of prulifloxacin: a comparison with other fluoroquinolones. Eur J Microbiol Infect Dis 2002;31:328-34.
31. Picollo R, Brion N, Gualano V, Millerioux L, Marchetti M, Rosignoli MT et al. Pharmacokinetics and tolerability of prulifloxacin after single oral administration. Arzneimittelforschung 2003;53:201-5.
32. Matera MG. Pharmacologic characteristics of prulifloxacin. Pulm Pharmacol Ther 2006;19 Suppl 1:20-9.
33. Yanaoka M, Kato S, Ando S, Okishio N, Asano H. Basic and clinical studies on NM441 in chronic bacterial prostatitis. Jpn Jo Chemother 1996;44 Suppl 1:405-13.
34. Prats G, Rossi V, Salvatori E, Mirelis B. Prulifloxacin: a new antibacterial fluoroquinolone. Expert Rev Anti Infect Ther 2006;4:27-41.
35. Cervigni M, Orticelli G, Bologna M, Natale F, Salvatori E, Di Loreto G et al. Single-dose prulifloxacin versus single-dose pefloxacin in the treatment of acute uncomplicated urinary tract infection in women. Urogynaecol Int 2003;17:69-77.
36. Carmignani G, De Rose AF, Olivieri L, Salvatori E, Rosignoli MT, Dionisio P. Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections. Urol Int 2005;74:326-31.
37. Prezioso D, Bartoletti R, Damiano R, Morgia G. Antibacterial prophylaxis in endourological procedures. Minerva Urol Nefrol 2006;58:73-80.
38. Pomara G, Dicuio M, Romano G, Campo G, Paperini D, Mogorovich A et al. Efficacia di ciprofloxacina e prulifloxacina nella prevenzione delle complicanze infettive in corso di mapping prostatico bioptico. Risultati di uno studio multicentrico, randomizzato, doppio cieco. Arch Ital Urol Androl 2005;77 Suppl 2:64.
39. Guercio S, Terrone C, Tarabuzzi R, Poggio M, Cracco C, Bollito E et al. PSA decrease after levofloxacin therapy in patients with histological prostatitis. Arch Ital Urol Androl 2004;76:154-8.